✦ LIBER ✦

Recommendations and rationale for the treatment of pelvic inflammatory disease

✍ Scribed by Jaiyeoba, Oluwatosin ;Lazenby, Gweneth ;Soper, David E

Book ID: 111679776
Publisher: Expert Reviews
Year: 2011
Tongue: English
Weight: 354 KB
Volume: 9
Category: Article
ISSN: 1478-7210
DOI: 10.1586/eri.10.156

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Diagnosis and treatment of pelvic inflam

Diagnosis and treatment of pelvic inflammatory disease

✍ Haggerty, Catherine L; Ness, Roberta B 📂 Article 📅 2008 🏛 Future Medicine 🌐 English ⚖ 426 KB

Nimesulide in the Treatment of Pelvic In

Nimesulide in the Treatment of Pelvic Inflammatory Diseases

✍ Chiantera, A.; Tesauro, R.; Di Leo, S.; Meli, M.T.; Scaricabarozzi, I 📂 Article 📅 1993 🏛 Springer International Publishing AG 🌐 English ⚖ 558 KB

Epidemiology, pathogenesis and treatment

Epidemiology, pathogenesis and treatment of pelvic inflammatory disease

✍ Haggerty, Catherine L ;Ness, Roberta B 📂 Article 📅 2006 🏛 Expert Reviews 🌐 English ⚖ 159 KB

Comparison of Three Regimens Recommended

Comparison of Three Regimens Recommended by the Centers for Disease Control and Prevention for the Treatment of Women Hospitalized with Acute Pelvic Inflammatory Disease

✍ Hemsell, D. L.; Little, B. B.; Faro, S.; Sweet, R. L.; Ledger, W. J.; Berkeley, 📂 Article 📅 1994 🏛 University of Chicago Press 🌐 English ⚖ 740 KB

C-reactive protein and the treatment of

C-reactive protein and the treatment of pelvic inflammatory disease

✍ M Reljič; B Gorišek 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 303 KB

Ampicillin/sulbactam vs. cefoxitin for t

Ampicillin/sulbactam vs. cefoxitin for the treatment of pelvic inflammatory disease

✍ Joseph G. Jemsek; Frank Harrison 📂 Article 📅 1997 🏛 Hindawi Publishing Corporation 🌐 English ⚖ 82 KB 👁 2 views

Objective: The safety and efficacy of ampicillin plus sulbactam were compared with those of cefoxitin in the treatment of women with pelvic inflammatory disease (PID). Methods: This single-site, randomized, prospective, third-party-blinded, comparative, paralleltreatment study enrolled 93 women wit